Simpson, Latham advise in $3.9 billion private equity buy
San Francisco private equity firm Hellman & Friedman LP and Washington, D.C.'s Carlyle Group agreed to buy North Carolina-based Pharmaceutical Product Development Inc. for $3.9 billion in cash in a going-private transaction. The company, which was advised by Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates and Wyrick Robbins Yates &am...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In